Skip to main content
Top
Published in: Supportive Care in Cancer 9/2016

01-09-2016 | Original Article

Socio-demographic and clinical variables associated with psychological distress 1 and 3 years after breast cancer diagnosis

Authors: Sven Alfonsson, Erik Olsson, Timo Hursti, Marie Høyer Lundh, Birgitta Johansson

Published in: Supportive Care in Cancer | Issue 9/2016

Login to get access

Abstract

Purpose

A large group of women (20–30 %) report psychological distress shortly after breast cancer diagnosis, and some experience continued or increased symptoms over time. The aim of this study was to investigate socio-demographic and clinical variables associated with sustained psychological distress in this patient group.

Methods

Women with breast cancer (n = 833) completed self-report questionnaires regarding socio-demographic and clinical variables shortly after (T1) and 3 years after diagnosis (T2) while data on illness severity were collected from a quality register. The Hospital Anxiety and Depression Scale was used as a measure of psychological distress at both time points.

Results

The number of participants who reported elevated levels of anxiety was 231 (28 %) at T1 and 231 (28 %) at T2 while elevated depressive symptoms was reported by 119 (14 %) women at T1 and 92 (11 %) at T2. Despite non-significant differences in mean scores over time, 91 (15 %) participants reported increased anxiety symptoms and 47 (7 %) reported increased depressive symptoms. Poor financial situation, lack of social support, previous psychiatric treatment, and high levels of fatigue were associated with both anxiety and depressive symptoms. Reporting high levels of fatigue was the variable most strongly associated with increased psychological distress over time.

Conclusion

Most participants reported decreased psychological distress over time, but there were subgroups of women who experienced sustained or increased symptoms of anxiety or depression. Participants with poor financial status, previous psychological problems, or high levels of fatigue may be at increased risk of psychological distress. Such individuals may benefit most from psychosocial interventions.
Literature
3.
go back to reference Antony MM, Stein MB (2009) Oxford handbook of anxiety and related disorders. Oxford University Press, New York Antony MM, Stein MB (2009) Oxford handbook of anxiety and related disorders. Oxford University Press, New York
4.
go back to reference Richards CS, O’Hara MW (2014) The Oxford handbook of depression and comorbidity. Oxford University Press, New YorkCrossRef Richards CS, O’Hara MW (2014) The Oxford handbook of depression and comorbidity. Oxford University Press, New YorkCrossRef
5.
go back to reference Stafford L et al (2015) Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer 23(8):2215–2224. doi:10.1007/s00520-014-2571-y CrossRefPubMed Stafford L et al (2015) Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer 23(8):2215–2224. doi:10.​1007/​s00520-014-2571-y CrossRefPubMed
8.
go back to reference Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743PubMed Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR (2000) Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 18:743PubMed
12.
16.
go back to reference Lundh MH, Lampic C, Nordin K, Ahlgren J, Bergkvist L, Lambe M et al (2013) Changes in health‐related quality of life by occupational status among women diagnosed with breast cancer—a population‐based cohort study. Psychooncology 22:2321–31. doi:10.1002/pon.3285 PubMed Lundh MH, Lampic C, Nordin K, Ahlgren J, Bergkvist L, Lambe M et al (2013) Changes in health‐related quality of life by occupational status among women diagnosed with breast cancer—a population‐based cohort study. Psychooncology 22:2321–31. doi:10.​1002/​pon.​3285 PubMed
17.
go back to reference Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K et al (2006) Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24:2420–7. doi:10.1200/JCO.2005.02.0081 CrossRefPubMed Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K et al (2006) Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 24:2420–7. doi:10.​1200/​JCO.​2005.​02.​0081 CrossRefPubMed
18.
go back to reference Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–76. doi:10.1093/jnci/85.5.365 CrossRefPubMed Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–76. doi:10.​1093/​jnci/​85.​5.​365 CrossRefPubMed
20.
go back to reference Jacobsen PB, Weitzner MA (2003) Evaluating the relationship of fatigue to depression and anxiety in cancer patients. In: Bruera E, Portenoy RK (eds) Issues in palliative care research. Oxford University Press, New York, pp 127–50 Jacobsen PB, Weitzner MA (2003) Evaluating the relationship of fatigue to depression and anxiety in cancer patients. In: Bruera E, Portenoy RK (eds) Issues in palliative care research. Oxford University Press, New York, pp 127–50
21.
go back to reference Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T et al (2000) Factors correlated with fatigue in disease-free breast cancer patients: application of the cancer fatigue scale. Support Care Cancer 8:215–22. doi:10.1007/s005200050288 CrossRefPubMed Okuyama T, Akechi T, Kugaya A, Okamura H, Imoto S, Nakano T et al (2000) Factors correlated with fatigue in disease-free breast cancer patients: application of the cancer fatigue scale. Support Care Cancer 8:215–22. doi:10.​1007/​s005200050288 CrossRefPubMed
23.
go back to reference Fors EA, Bertheussen GF, Thune I, Juvet LK, Elvsaas IKØ, Oldervoll L et al (2011) Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review. Psychooncology 20:909–18. doi:10.1002/pon.1844 PubMed Fors EA, Bertheussen GF, Thune I, Juvet LK, Elvsaas IKØ, Oldervoll L et al (2011) Psychosocial interventions as part of breast cancer rehabilitation programs? Results from a systematic review. Psychooncology 20:909–18. doi:10.​1002/​pon.​1844 PubMed
24.
go back to reference Mattsson S, Alfonsson S, Carlsson M, Nygren P, Olsson E, Johansson B (2013) Internet-based stepped care with interactive support and cognitive behavioral therapy for reduction of anxiety and depressive symptoms in cancer—a clinical trial protocol. BMC Cancer 13(1):1CrossRef Mattsson S, Alfonsson S, Carlsson M, Nygren P, Olsson E, Johansson B (2013) Internet-based stepped care with interactive support and cognitive behavioral therapy for reduction of anxiety and depressive symptoms in cancer—a clinical trial protocol. BMC Cancer 13(1):1CrossRef
27.
go back to reference Kangas M, Bovbjerg DH, Montgomery GH (2008) Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 134:700. doi:10.1037/a0012825 CrossRefPubMed Kangas M, Bovbjerg DH, Montgomery GH (2008) Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients. Psychol Bull 134:700. doi:10.​1037/​a0012825 CrossRefPubMed
28.
Metadata
Title
Socio-demographic and clinical variables associated with psychological distress 1 and 3 years after breast cancer diagnosis
Authors
Sven Alfonsson
Erik Olsson
Timo Hursti
Marie Høyer Lundh
Birgitta Johansson
Publication date
01-09-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-016-3242-y

Other articles of this Issue 9/2016

Supportive Care in Cancer 9/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine